from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0311/-

LFCtreatmentdescriptionclass of inhibitor

-0.330

Amikacinug/mL Amikacintranslation

-0.344

Cap5-10ug/mL Capreomycintranslation

-0.432

Rox10-50 ug/mL Roxithromycintranslation

-0.661

SM2-5 ug/mL Streptomycintranslation

-1.205

Tet5-10 ug/mL Tetracyclinetranslation

0.045

Rif0.2-5ug/mL Rifampicintranscription

-0.446

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.390

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.012

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.093

CPZ10-50 ug/mL Chlorpromazinerespiration

0.812

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.265

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.695

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.213

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.795

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.173

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.404

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.051

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.903

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.478

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.364

KCN5-20 ug/mL Potassium cyaniderespiration

-0.341

NaN30.2-2 mM Sodium aziderespiration

0.043

Nigericin50 uM Nigericinrespiration

1.279

TRC10-150 ug/mL Triclosanrespiration

1.731

TRZ10-25 ug/mL Thioridazinerespiration

-0.245

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.472

menadione6-10 ug/mL Menadionerespiration

0.023

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.566

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.551

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.670

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.192

NRP_1Non-replicating persistence stage 1dosRassociated

-0.570

Amp0.2mg/mL AmpicillincellWall

-0.626

Cephalexin20-100 ug/mL CephalexincellWall

0.237

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.272

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.305

EMB10-20 ug/mL EthambutolcellWall

-0.261

Eta12-40 ug/mL EthionamidecellWall

-0.269

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.229

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.482

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.804

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.066

BZA0.12 mg/mL BenzamidearomaticAmides

-0.247

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.353

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.191

H2O24 mM hydrogen peroxideDNAdamaging

-0.550

Levo10 ug/mL LevofloxacinDNAdamaging

-0.290

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.048

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.287

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.452

UVUV-irradiationDNAdamaging

0.730

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.512

Antimycin12.5-50 ug/mL Antimycin A?

-0.403

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.420

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.542

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.158

PA8240.2-2 ug/mL PA-824?

1.149

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.113

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.282

Verapamil50 uM Verapamil?

-0.211

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.736

methoxatin10-20 ug/mL Methoxatin?